Smith Sandford D
- SEC CIK
- 0001243004
No open-market purchases or sales filed in the past year.
Current role at each company
- CYTK Cytokinetics IncDirectoras of Jan 3, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith Sandford D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 (view filing) | Sep 2 | Same day | Smith Sandford DDirector | SSale | −11.4K | $53.97 | −$613.6K | −48.3%12.2K after | |
| Dec 28, 2021 (view filing) | Dec 27 | 1 day | Smith Sandford DDirector | SSale | −28.3K | $45.79 | −$1.30M | −80.7%6.76K after | 3 lots |
| Nov 19, 2021 (view filing) | Nov 19 | Same day | Smith Sandford DDirector | SSale | −29.0K | $41.21 | −$1.20M | −81.1%6.76K after | 3 lots |
| Jul 21, 2021 (view filing) | Jul 19 | 2 days | Smith Sandford DDirector | SSale | −12.0K | $28.87 | −$345.5K | −64.9%6.46K after | 3 lots |